ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 258 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,951,000 | +56.1% | 21,000 | 0.0% | 0.44% | +44.5% |
| Q3 2021 | $1,250,000 | -12.6% | 21,000 | 0.0% | 0.30% | -20.4% |
| Q2 2021 | $1,431,000 | -1.8% | 21,000 | 0.0% | 0.38% | -1.8% |
| Q1 2021 | $1,457,000 | +18.1% | 21,000 | +27.3% | 0.38% | -3.3% |
| Q3 2020 | $1,234,000 | +19.0% | 16,500 | 0.0% | 0.40% | +15.4% |
| Q2 2020 | $1,037,000 | +50.3% | 16,500 | 0.0% | 0.34% | +9.5% |
| Q1 2020 | $690,000 | -7.9% | 16,500 | 0.0% | 0.32% | +16.7% |
| Q4 2019 | $749,000 | -0.8% | 16,500 | 0.0% | 0.27% | -22.6% |
| Q3 2019 | $755,000 | -21.9% | 16,500 | 0.0% | 0.35% | -2.8% |
| Q2 2019 | $967,000 | +30.7% | 16,500 | 0.0% | 0.36% | +31.5% |
| Q1 2019 | $740,000 | – | 16,500 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 163,133 | $7,467,000 | 4.14% |
| PFM Health Sciences, LP | 2,271,536 | $103,968,000 | 3.07% |
| Partner Investment Management, L.P. | 28,877 | $1,322,000 | 2.26% |
| Atika Capital Management LLC | 181,000 | $8,284,000 | 1.74% |
| DAFNA Capital Management LLC | 93,942 | $4,300,000 | 1.62% |
| Asymmetry Capital Management, L.P. | 16,272 | $745,000 | 1.60% |
| First Light Asset Management, LLC | 190,838 | $8,735,000 | 1.32% |
| Perceptive Advisors | 953,129 | $43,624,000 | 1.18% |
| Rhenman & Partners Asset Management AB | 155,000 | $7,094,000 | 0.89% |
| Opus Point Partners Management, LLC | 9,770 | $447,000 | 0.81% |